Assembly Resolution No. 38 designates May 2025 as Brain Tumor Awareness Month in California and directs the Assembly Chief Clerk to send copies of the resolution to the author for distribution. The text assembles a series of WHEREAS clauses emphasizing the disease burden — including national prevalence and five-year survival statistics for malignant brain tumors and glioblastoma — and notes Los Angeles as home to a major brain tumor center.
This resolution is purely ceremonial: it does not appropriate funds, change law, or impose duties on state agencies beyond clerical transmission. Its practical value lies in giving advocates, hospitals, and local governments a formal statewide designation they can cite when organizing outreach, fundraising, education, or research visibility efforts.
At a Glance
What It Does
The measure declares May 2025 to be Brain Tumor Awareness Month in California via an Assembly resolution and collects factual WHEREAS statements about prevalence and survival rates. It includes a procedural instruction for the Chief Clerk to transmit copies to the author for distribution.
Who It Affects
Primary beneficiaries are patient groups, medical centers, researchers, and advocacy organizations that use official designations to coordinate events or public information. The resolution imposes no new regulatory or budgetary obligations on state agencies or local governments.
Why It Matters
Official designations matter practically because they make it easier to market awareness campaigns, attract donors, and align stakeholder communications; they do not, however, create new funding streams or change healthcare delivery or research mandates.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
AR 38 is an Assembly resolution that performs two straightforward tasks: it documents a set of facts about brain tumors and then uses those facts to declare May 2025 as Brain Tumor Awareness Month in California. The bill's factual statements emphasize the scale of need (an estimated 1 million Americans living with a primary brain tumor), low survival rates for malignant tumors overall and for glioblastoma in particular, and the presence of a leading brain tumor center in Los Angeles.
Those findings form the factual basis for the symbolic month-long designation.
The operative language is short and procedural: the Assembly 'declares' the month and orders that copies of the resolution be transmitted by the Chief Clerk to the author so they can be distributed. The resolution does not create enforceable obligations, direct agencies to take actions, fund programs, or alter existing law.
It is therefore a formal expression of legislative sentiment rather than a statute or appropriations measure.Because it is symbolic, the resolution's main downstream effect is communicative: advocacy groups, hospitals, and research centers can cite the Assembly's declaration in publicity, solicitations, and event planning. The resolution also codifies specific statistics and talking points in the legislative record, which can be useful to stakeholders seeking a concise, authoritative summary for awareness materials.Finally, by naming Los Angeles as a home to a leading brain tumor center and highlighting survival statistics, the resolution creates a framing device that local institutions can use to coordinate public education and fundraising efforts during May 2025.
That said, any material or programmatic responses will depend on separate funding or administrative decisions outside the resolution itself.
The Five Things You Need to Know
The resolution declares the month of May 2025 to be Brain Tumor Awareness Month in California.
It lists key statistics in its WHEREAS clauses: an estimated 1,000,000 Americans living with a primary brain tumor and a 36% five‑year relative survival rate for malignant brain tumors.
For glioblastoma the resolution cites a 5‑year relative survival rate of 6.8% and a median survival of eight months.
The only operative directive is administrative: the Chief Clerk must transmit copies of the resolution to the author for distribution.
AR 38 is a ceremonial Assembly resolution and does not appropriate funds, create regulatory duties, or change existing law.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Evidence and factual record for the designation
This cluster of clauses compiles prevalence and outcome statistics and briefly describes the human impact of brain tumors. Practically, the WHEREAS text locks a set of talking points into the legislative record that stakeholders can quote without running afoul of accuracy challenges; it also signals legislative awareness of the clinical urgency, particularly for glioblastoma.
Formal declaration of Brain Tumor Awareness Month
A single RESOLVED clause accomplishes the core legal act: the Assembly declares May 2025 as Brain Tumor Awareness Month. Because this is a resolution rather than a statute, the declaration carries symbolic weight but no binding legal or fiscal effect on state agencies or private parties.
Clerical instruction to circulate the resolution
The resolution directs the Chief Clerk of the Assembly to transmit copies to the author for distribution. This is a ministerial step that facilitates dissemination to stakeholders, press, and advocacy groups; it does not require the Assembly to fund or staff distribution efforts beyond routine clerical functions.
Editorial revision recorded
A short revision line indicates an edit to the heading. It is an administrative notation with no substantive policy effect but useful for tracking the version of the text that contains the recorded WHEREAS language and operative clauses.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Brain tumor patients and families — they gain a statewide, formal designation that advocacy groups and care providers can cite to increase visibility, fundraising, and community support.
- Medical centers and researchers (particularly in Los Angeles) — they can use the Assembly's designation and the embedded statistics in communications to promote research initiatives, recruit clinical-trial participants, and coordinate public events.
- Advocacy and nonprofit organizations focused on brain tumors — the resolution provides a legislative anchor for awareness campaigns, volunteer recruitment, and donor appeals during May 2025.
Who Bears the Cost
- Assembly administrative staff — minor clerical time to transmit copies and maintain the legislative record, absorbed within routine operations.
- Local organizations and hospitals that choose to run events — these actors may incur outreach, staffing, and programming costs without any new state funding tied to the designation.
- Stakeholders expecting policy change — patient advocates seeking funding or regulatory action bear an opportunity cost if they treat the resolution as a substitute for lobbying on concrete legislative or budgetary measures.
Key Issues
The Core Tension
The central tension is between symbolic recognition and concrete change: the resolution boosts visibility and gives advocates a legislative platform, but it stops short of funding, mandates, or programmatic commitments — leaving stakeholders to weigh whether the formal designation is sufficient to advance urgent needs or merely a public-relations tool.
The resolution's primary limitation is its symbolic nature. It collects persuasive statistics and issues a formal declaration, but it creates no budget authority, no new program, and no requirement for state agencies to act.
That means expected benefits — improved access to services, increased research funding, or expanded clinical trials — will only happen if separate legislative, administrative, or private actions follow.
A second challenge is expectation management. Official designations can raise public expectations for support or policy change.
Without accompanying appropriations or mandates, advocacy groups may find it harder to convert heightened attention into concrete resources. There is also a practical question of equity and reach: the resolution names a prominent Los Angeles center, but it does not address how rural or underresourced communities will share in outreach or services generated by the awareness month.
Finally, the resolution embeds specific survival statistics and clinical descriptors in the legislative record; those numbers provide clarity but also create a static reference point that may be cited in future policy discussions. If medical understanding or epidemiology shifts, stakeholders may need to reconcile newer data with the text of the resolution when using it in outreach or legislative advocacy.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.